Literature DB >> 2477052

Enhancement and suppression of DTH reactivity to Rauscher murine leukaemia virus induced tumour cell lines.

A C Knulst1, D Berends, C Bazuin, H C van Rooij, N J de Both, R Benner.   

Abstract

Delayed-type hypersensitivity (DTH) to Rauscher murine leukaemia virus (R-MuLV) encoded or induced determinants was induced in mice by three syngeneic R-MuLV-induced tumour cell lines, i.e. a myeloid tumour, RMB-1, an erythroid tumour, RED-1, and a lymphoid tumour, RLD-1. DTH to subcutaneously (s.c.) administered RMB-1 cells appeared on day 4, with a maximum DTH response on day 6 or 7. The induction of DTH could be prevented by intravenous (i.v.) pre-immunisation with R-MuLV-induced tumour cells several days before the s.c. immunisation. The three R-MuLV-induced tumour cell lines showed cross-reactivity in the DTH assay, whereas no cross-reactivity was found with syngeneic WEHI-3 cells. This indicates that the three R-MuLV-induced tumour cell lines share a virally encoded or induced antigenic determinant, which activates T-cells. When the RMB-1 cells used for immunisation had been cultured in medium supplemented with interferon-gamma (IFN-gamma), the subsequent DTH response was increased. This coincided with an increased expression of the R-MuLV-specific antigenic determinants on RMB-1 cells as demonstrated by Scatchard analysis. Furthermore, IFN-gamma increased the MHC class I antigen expression on RMB-1 cells, whereas the class II antigen expression remained undetectable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477052      PMCID: PMC2247201          DOI: 10.1038/bjc.1989.284

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Adoptive chemoimmunotherapy of murine leukemia with helper T lymphocyte clones.

Authors:  M A Bookman; R Swerdlow; L A Matis
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

2.  Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma.

Authors:  W R Green; J D Phillips
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

Review 3.  Down-regulation of the antitumor immune response.

Authors:  R J North
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.

Authors:  T Suda; H Fujiwara; Y Mizushima; G M Shearer; T Hamaoka
Journal:  J Natl Cancer Inst       Date:  1986-12       Impact factor: 13.506

5.  The Lyt phenotype of the T cells responsible for in vivo tumor rejection in syngeneic mice.

Authors:  H Ozawa; T Iwaguchi; T Kataoka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

7.  The detection of virally induced tumors by 131I- and 125I-labeled syngeneic monoclonal antibodies.

Authors:  D Berends; J L van Gaalen; E H Rhijnsburger; N J de Both; W Breeman; W H Bakker; P Kooy
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo.

Authors:  J W Greiner; F Guadagni; P Noguchi; S Pestka; D Colcher; P B Fisher; J Schlom
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

9.  Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells.

Authors:  K Tanaka; H Hayashi; C Hamada; G Khoury; G Jay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Induction of "innocent bystander" cytotoxicity in nonimmune mice by adoptive transfer of L3T4+ Lyt-1+2- mammary tumor immune T-cells.

Authors:  R D Paul; D M Lopez
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.